As previously reported,[32] IFN‐β treatment significantly inhibited the proliferation of the B16‐F10 melanoma cells, whereas knockout of cGAS and IRF3 reversed the inhibitory effects of IFN‐β (Figure 7A,B). Here, IRF3 is linked to melanoma.